Intergenic interactions of TNFα, IL-17, and osteoprotegerin in the immunopathogenesis of rheumatoid arthritis in the Russian population of Chelyabinsk Region

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that predominantly affects small joints, causing persistent pain, functional impairment, and a marked reduction in patients’ quality of life. The pathological process is characterized by ongoing synovial inflammation, destruction of cartilage and subchondral bone, and extra-articular manifestations involving the cardiovascular, pulmonary, and nervous systems. A key pathogenetic factor seems to be an imbalance between pro- and anti-inflammatory mediators, among which tumour necrosis factor-a (TNFa), interleukins IL-17A and IL-17F, and osteoprotegerin (TNFRSF11B), a regulator of osteoclast differentiation, play central roles. The present study aimed to assess the contribution of polymorphisms in the TNFA, IL17A, IL17F, and TNFRSF11B genes to individual susceptibility to RA in the Russian population of the Chelyabinsk Region. We hypothesized that the major genetic impact on disease development may be produced not only by single nucleotide variants but also by their combined multilocus constellations. Special attention was given to intergenic interactions, which are often underestimated in most association studies. Genotyping was performed by polymerase chain reaction (PCR). To evaluate the data, we applied the multifactor dimensionality reduction (MDR) algorithm, which constructs predictive case–control models and evaluates their robustness by means of ten-fold cross-validation and permutation testing. The algorithm identified three most informative combinations comprising four to six SNPs each; every combination showed statistical significance and high predictive accuracy. Cross-validation consistency values exceeded 9/10, indicating excellent reproducibility of the models. These findings confirm that a comprehensive multilocus genotype analysis is more informative than examining individual markers alone and it may be used for patient risk stratification, early diagnosis, and development of personalised preventive strategies based on targeted anti-cytokine therapies. Further studies in larger cohorts are needed to validate these results.

1. Vavilin V.A., Goreva O.B., Shebunyaeva Ya.Yu., Makarova S.I., Voitko M.S., Grishanova A.Yu., Pospelova T.I. The role of polymorphic variants of the CYP3A4, CYP3A5, CYP1A1 and CYP2D6 genes in the development of genotoxic effects of chemotherapy in patients with Hodgkin’s lymphoma. Farmakogenetika i farmakogenomika = Pharmacogenetics and Pharmacogenomics, 2024, no. 1, pp. 31-43. (In Russ.)

2. Ziyadullaev S.K., Ashenbayeva E.N., Kireev V.V., Suyarov A.A. Immunological markers of systemic inflammation in rheumatoid arthritis. Vestnik ekstrennoy meditsiny = Bulletin of Emergency Medicine, 2020, Vol. 13, no, 5, pp. 102-111. (In Russ.)

3. Ignatenko G.A., Nemsadze I.G., Mirovich E.D., Churilov A.V., Mailyan E.A., Glazkov A.E., Rumyantseva Z.S. The role of cytokines in bone remodeling and the pathogenesis of postmenopausal osteoporosis. Meditsinskiy vestnik Yuga Rossii = Medical Bulletin of the South of Russia, 2020, Vol. 11, no. 2, pp. 6-18. (In Russ.)

4. Kostareva O.S. Interleukin-17: functional and structural features; use as a therapeutic target. Uspekhi biologicheskoy khimii = Advances in Biological Chemistry, 2019, Vol. 59, pp. 393-418. (In Russ.)

5. Lebed T.L., Zhur N.V., Shepelevich N.V. Reduction of multifactorial dimension (MDR analysis) in genetic research. Rossiyskiy zhurnal informatsionnykh tekhnologiy v sporte = The Russian Journal of Information Technologies in Sports, 2024, no. 3, pp. 16-21. (In Russ.)

6. Rykunova A.Ya., Zverev Ya.F. Modern concepts of the pathogenesis of rheumatoid arthritis. Patologicheskaya fiziologiya i eksperimentalnaya terapiya = Pathological Physiology and Experimental Therapy, 2024. Vol. 68, no. 4, pp. 59-70. (In Russ.)

7. Stashkevich D.S., Khromova E.B., Dewald I.V., Hodus E.A., Burmistrova A.L. Expanded haplotypes based on rare single nucleotide polymorphisms TNF A and HLA DRB1 in association with rheumatoid arthritis. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2021, Vol. 24, no. 4, pp. 555-562. (In Russ.) doi: 10.46235/1028-72211053-EHB.

8. Shmelkova D.M., Stashkevich D.S., Suslova T.A., Devald I.V. Single nucleotide polymorphism of IL-17F as a possible biomarker of rheumatoid arthritis in the Russian population of the Chelyabinsk region and its nonequilibrium coupling with IL-17A. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2024, Vol. 27, no. 3, pp. 523-530. (In Russ.) doi: 10.46235/1028-7221-16775-SNP.

9. Chumicheva Yu.V., Stashkevich D.S., Devald I.V., Suslova T.A. Single nucleotide polymorphism of osteoprotegerin as a possible biomarker of rheumatoid arthritis in the Bashkir population of the Chelyabinsk region. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2023, Vol. 26, no. 4, pp. 521-526. (In Russ.) doi: 10.46235/1028-7221-13964-SNP.

10. Yurova K.A., Khaziakhmetova O.G., Malashenko V.V., Norkin I.K., Ivanov P.A., Khlusov I.A., Shunkin E.O., Todosienko N.M., Melashchenko E.S., Litvinova L.S. Cellular and molecular aspects of inflammation, angiogenesis and osteogenesis. Tsitologiya = Tsitologiya, 2020, Vol. 62, no. 5, pp. 305-315. (In Russ.)

11. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol., 2009, Vol. 9, no. 8, pp. 556-567.

12. Kawaguchi M., Takahashi D., Hizawa N., Suzuki S., Matsukura S., Kokubu F., Maeda Y., Fukui Y., Konno S., Huang S.-K., Nishimura M., Adachi M. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J. Allergy Clin. Immunol., 2006, Vol. 117, no. 4, pp. 795-801.

13. Nava-Valdivia C.A., Saldaña-Cruz A.M., Corona-Sanchez E.G., Murillo-Vazquez J.D., Moran-Moguel M.C., Salazar-Paramo M., Perez-Guerrero E.E., Vazquez-Villegas M.L., Bonilla-Lara D., Rocha-Muñoz A.D., MartínMarquez B.T., Sandoval-Garcia F., Martínez-García E.A., Fajardo-Robledo N.S., Ponce-Guarneros J.M., RamirezVillafaña M., Alcaraz-Lopez M.F., Gonzalez-Lopez L., Gamez-Nava J.I. Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis. J. Immunol. Res., 2017, Vol. 2017, 7680434. doi: 10.1155/2017/7680434.